drugset / Trial / NCT05603052
A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A phase III, randomized, observer-blind, active-controlled, parallel-group, multi-center study to evaluate immunogenicity and safety of a preventive COVID-19 vaccine EuCorVac-19 in healthy adults aged 18 years and older
Timeline
- Start
- 2022-07-11
- Primary completion
- 2024-01-15
- Completion
- 2024-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD1222 | Vaccine | — | — |
| Subject | EuCorVac-19 | Vaccine | — | — |